Literature DB >> 9851646

Early diagnosis of ALS/MND.

M Swash1.   

Abstract

With the advent of a specific biological therapy for ALS there is an increasing imperative for early diagnosis. As new, more effective therapies become available, this will become more important. It is intuitively probable that early therapy will prevent disability in this otherwise relentlessly progressive disorder. The difficulties posed by this need for early diagnosis in clinical practice are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851646     DOI: 10.1016/s0022-510x(98)00215-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Amyotrophic lateral sclerosis presenting as upper limb weakness in a 35 year old female: a case report.

Authors:  Leif A Sigurdson
Journal:  J Can Chiropr Assoc       Date:  2011-09

2.  Superconditioning TMS for examining upper motor neuron function in MND.

Authors:  Blair Calancie; Eufrosina Young; Mary Lou Watson; Dongliang Wang; Natalia Alexeeva
Journal:  Exp Brain Res       Date:  2019-06-07       Impact factor: 1.972

3.  Amyotrophic lateral sclerosis: update and new developments.

Authors:  Ashley J Pratt; Elizabeth D Getzoff; J Jefferson P Perry
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-02

4.  Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits.

Authors:  M S Petrik; J M B Wilson; S C Grant; S J Blackband; R C Tabata; X Shan; C Krieger; C A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

5.  The puzzling case of hyperexcitability in amyotrophic lateral sclerosis.

Authors:  Jong Seok Bae; Neil G Simon; Parvathi Menon; Steve Vucic; Matthew C Kiernan
Journal:  J Clin Neurol       Date:  2013-04-04       Impact factor: 3.077

6.  Applications and limitations of current markerless motion capture methods for clinical gait biomechanics.

Authors:  Logan Wade; Laurie Needham; Polly McGuigan; James Bilzon
Journal:  PeerJ       Date:  2022-02-25       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.